A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Radiation Oncology Residency Program Bookmark and Share

Radiation Oncology Residency Program

The City of Hope Radiation Oncology Residency Program is a four-year Accreditation Council for Graduate Medical Education (ACGME) accredited program which begins in the PGY-2 year. The overall goal of the program is to train physicians to be outstanding radiation oncologists and to provide graduates with a solid foundation in translational and clinical research. The program emphasizes preparation for careers in academic radiation oncology. The selection process gives preference to those applicants who show an aptitude for academic medicine and with an interest in teaching, research and the application of cutting-edge translational technologies to cancer care.

Training is provided in clinical radiation oncology, treatment planning, radiation physics, and radiobiology, equipping graduates to provide comprehensive patient care as practicing radiation oncologists either in academia or the private practice setting. Residents actively participate in the management of a diverse variety of patients, with progressively increasing responsibilities during later phases of the Program. The attending physicians and the resident physicians work as a team, with the resident assuming primary care responsibilities for patients under the attending’s supervision. The resident-attending teams evaluate and counsel new patients and provide treatment which includes radiotherapy simulation, treatment planning, and administration of irradiation. The resident physician follows the patient throughout treatment with attending supervision and subsequently in post-radiotherapy follow-up clinics.

Please refer to Resident Handbook for complete outline of Program Year Objectives.

The total complement of residents is four, with one resident currently being accepted per year into the program. The program participates in the National and Resident Matching Program, with applications processed through the Electronic Residency Application Service (ERAS) common application program. (Refer to Application Process for more information)

City of Hope continues to be on the forefront of the latest treatment technology and clinical research, providing residents with a rich and comprehensive training environment. As an NCI designated comprehensive cancer center and charter member of the NCCN, City of Hope provides an excellent environment for residency education. A major and extensive renovation is underway that will increase the clinical area to 29,000 square feet with 4 treatment vaults, 3 imaging suites, a new clinic area and expansion of treatment planning and physics work space. Two  Tomotherapy units, a Varian Trilogy and Varian IX will be installed. Multimodality functional tumor imaging will be a key part of the new center which will house MRI, PET/CT and CT units dedicated to treatment planning and treatment response assessment. In addition to these resources, radiation biology labs occupying a total of 4-5000 square feet currently house the labs of 4 NCI funded basic lab scientists. Finally an additional 8000 square feet is dedicated to an established radioimmunotherapy program with basic science laboratories and a radiopharmacy for the labeling of preclinical and clinical radiopharmaceuticals for tumor imaging and targeted tumor therapy.

Formal lectures cover radiation biology, physics, and clinical radiation oncology. clinical trial design, biostatistics, imaging (PET, SPECT, MRI,etc.), medical oncology and pediatric oncology. Multidisciplinary training will be emphasized. City of Hope has established fellowship programs in medical oncology, hematologic oncology, pathology, surgery, and urology. Ample interaction occurs through clinical conferences and tumor boards. Electives will be available with the other oncologic specialties.

Each resident will also be required to do an 8-12 month research rotation. He or she will select a lab or clinical research project to pursue, with the goal of publishing at least 2 manuscripts in peer-reviewed journals.

In accordance with the American Board of Radiology (ABR) for board eligibility, City of Hope requires successful completion of a clinical PGY1 year in the United States prior to commencing its four-year Radiation Oncology Residency Program.
 
 
Using leading edge technology, the Department of Radiation Oncology offers specialized services in external beam radiation therapy, radioactive seed implantation for prostate cancer, stereotactic radiosurgery and image guided intensity modulated radiation therapy. We also offer novel approaches to cancer therapy, such as radioimmunotherapy and helical tomotherapy. Through innovative laboratory and clinical research programs, we continue to investigate ways to further advance the efficacy and safety of radiation therapy.

Application Process

How to Apply
 
 
Application Checklist
 
  • ERAS application
  • Official college, graduate school and medical school transcripts
  • An official record of board scores (NBME, FLEX, USMLE, LMCC, COMLEX, VQE or FMGEMS).
  • A dean's letter and two other letters of recommendation.
  • A curriculum vita.
  • A personal statement.
 
 
Graduates from a medical school outside of the United States or Canada must submit a valid ECFMG certificate.

Applications for each academic year, which begins July 1, should be completed by December 1 of the previous calendar year. If you are selected for an interview, you will be invited to visit City of Hope for an interview with selected faculty. Interviews are conducted from late November through early February each year.
 
Contact
 
For further information, contact the program by phone or email:
 
Thalia Yaden
Residency Program Coordinator
City of Hope Department of Radiation Oncology
1500 E. Duarte Road, Duarte, CA 91010
Telephone: 626-301-8247, ext. 64163
radiationresident@coh.org
 

Faculty

In addition to caring for patients in their clinical practices, the City of Hope Department of Radiation Oncology faculty members are committed to teaching and facilitating the growth of medical knowledge.

Faculty members in the Department of Radiation Oncology include:
 
Radiation Oncologists:
 
  • Jeffrey Wong, M.D., FASTRO Chair
 
  • Eric Radany, M.D., Ph.D., Program Director
 
  • Richard Pezner, M.D.
 
  • Nayana Vora, M.D.
 
  • Yi-Jen Chen, M.D., Ph.D.
 
  • Khanh Nguyen, M.D.
 
  • Andrew Raubitschek, M.D. (Radioimmunotherapy)
 
 
 
Physicist:
 
  • Timothy Schultheiss, Ph.D. FACR, FAAPM, FASTRO, Director of Radiation Physics Cecil Staud, Ph.D.
 
  • An Liu, Ph.D.
 
  • Chun-Hui Han, Ph.D.
 
  • Sean Sun, M.S.
 
  • Lawrence Williams, Ph.D., FACR (Diagnostic Imaging)
 
  • James Bading, Ph.D. (Radioimmunotherapy)
 
 
 
Radiation Biology
 
  • Binghui Shen, Ph.D., Director, Radiation Biology
 
  • Jeremy Stark, Ph.D.
 
  • Fong-Fong Chu, Ph.D.
 

Facility and Department

City of Hope is recognized worldwide for its compassionate patient care, innovative science and translational research, which rapidly turns laboratory breakthroughs into promising new therapies. We are one of only 41 National Cancer Institute-designated Comprehensive Cancer Centers nationwide and a founding member of the National Comprehensive Cancer Network. 
 
On our park-like campus just northeast of Los Angeles, City of Hope Helford Clinical Research Hospital brings groundbreaking research and compassionate care under one roof. It embodies our mission to deliver the newest, most promising therapies to patients without delay, while creating an environment that encourages open collaboration between physicians, caregivers and clinical researchers.
 
City of Hope Department of Radiation Oncology treats more than 900 patients each year. The department is equipped with state-of-the art technology, with facility renovation underway.  The department offers the full spectrum of radiation therapy modalities, including:
 
  • External beam radiation therapy with high-energy photons and electrons.
  • 3-D Conformal Radiation Therapy
  • IMRT -- Intensity Modulated Radiation Therapy
  • IGRT -- Image Guided Radiation Therapy
  • Stereotactic Radiosurgery
  • Total Body and Total Marrow Irradiation in conjunction with a Bone Marrow Transplant
  • Brachytherapy with LDR and HDR techniques
  • Treatment with Unsealed Sources, including targeted radiopharmaceuticals and radio-immunotherapy
 
 

Therapy Equipment 
 
  • Two Helical TomoTherapy – IGRT units
  • One Varian 21EX dual energy (6 MeV and 10 MeV), MLC linear accelerators with multiple electron capability and IMRT
  • One 6 MeV Varian linear accelerators.
  • Varian high dose-rate afterloader for interstitial and intracavitary implants.
  • Variety of low dose-rate sources available for implantation.
  • Ultrasound guided equipment for permanent prostate seed implants. Equipment to be added soon
  • One Varian Trilogy dual energy with CBCT/OBI and SRS/SRT capable.
  • One Varian iX dual energy accelerator with CBCT/OBI
 
Planning / Verification Equipment
 
  • Large bore CT-Simulation unit, dedicated for treatment planning
  • One Varian conventional simulator
  • Varian Eclipse Treatment Planning System
  • TomoTherapy Treatment Planning System
  • IMPAC Radiation Oncology Management System
 
Planning Equipment to be added soon
 
  • GE multi slice PET/CT simulator dedicated to planning and response assessment
  • GE 1.5T MRI dedicated to radiation oncology planning and response assessment
 
Conferences
Residents will be required to attend various radiation oncology conferences each week, as well as multidisciplinary conferences. An integrated, multidisciplinary approach to patient management is stressed. 
 
Multidisciplinary clinics or tumor boards occur in breast cancer; GU/prostate cancer, sarcomas, head and neck cancers; pediatric cancers; gynecological malignancies; gastrointestinal cancers; central nervous system cancers; and lymphomas. There is frequent interaction between all specialties which care for these patients including medical oncology, pediatric oncology, general surgery, head and neck surgery, the bone marrow transplantation service, pain service, neurosurgery, gynecological oncologists, thoracic surgery, and other ancillary services. 
 
Residents are a vital and important part of this multidisciplinary approach to the treatment of patients with cancer.
 

Radiation Oncology Residency Program

Radiation Oncology Residency Program

The City of Hope Radiation Oncology Residency Program is a four-year Accreditation Council for Graduate Medical Education (ACGME) accredited program which begins in the PGY-2 year. The overall goal of the program is to train physicians to be outstanding radiation oncologists and to provide graduates with a solid foundation in translational and clinical research. The program emphasizes preparation for careers in academic radiation oncology. The selection process gives preference to those applicants who show an aptitude for academic medicine and with an interest in teaching, research and the application of cutting-edge translational technologies to cancer care.

Training is provided in clinical radiation oncology, treatment planning, radiation physics, and radiobiology, equipping graduates to provide comprehensive patient care as practicing radiation oncologists either in academia or the private practice setting. Residents actively participate in the management of a diverse variety of patients, with progressively increasing responsibilities during later phases of the Program. The attending physicians and the resident physicians work as a team, with the resident assuming primary care responsibilities for patients under the attending’s supervision. The resident-attending teams evaluate and counsel new patients and provide treatment which includes radiotherapy simulation, treatment planning, and administration of irradiation. The resident physician follows the patient throughout treatment with attending supervision and subsequently in post-radiotherapy follow-up clinics.

Please refer to Resident Handbook for complete outline of Program Year Objectives.

The total complement of residents is four, with one resident currently being accepted per year into the program. The program participates in the National and Resident Matching Program, with applications processed through the Electronic Residency Application Service (ERAS) common application program. (Refer to Application Process for more information)

City of Hope continues to be on the forefront of the latest treatment technology and clinical research, providing residents with a rich and comprehensive training environment. As an NCI designated comprehensive cancer center and charter member of the NCCN, City of Hope provides an excellent environment for residency education. A major and extensive renovation is underway that will increase the clinical area to 29,000 square feet with 4 treatment vaults, 3 imaging suites, a new clinic area and expansion of treatment planning and physics work space. Two  Tomotherapy units, a Varian Trilogy and Varian IX will be installed. Multimodality functional tumor imaging will be a key part of the new center which will house MRI, PET/CT and CT units dedicated to treatment planning and treatment response assessment. In addition to these resources, radiation biology labs occupying a total of 4-5000 square feet currently house the labs of 4 NCI funded basic lab scientists. Finally an additional 8000 square feet is dedicated to an established radioimmunotherapy program with basic science laboratories and a radiopharmacy for the labeling of preclinical and clinical radiopharmaceuticals for tumor imaging and targeted tumor therapy.

Formal lectures cover radiation biology, physics, and clinical radiation oncology. clinical trial design, biostatistics, imaging (PET, SPECT, MRI,etc.), medical oncology and pediatric oncology. Multidisciplinary training will be emphasized. City of Hope has established fellowship programs in medical oncology, hematologic oncology, pathology, surgery, and urology. Ample interaction occurs through clinical conferences and tumor boards. Electives will be available with the other oncologic specialties.

Each resident will also be required to do an 8-12 month research rotation. He or she will select a lab or clinical research project to pursue, with the goal of publishing at least 2 manuscripts in peer-reviewed journals.

In accordance with the American Board of Radiology (ABR) for board eligibility, City of Hope requires successful completion of a clinical PGY1 year in the United States prior to commencing its four-year Radiation Oncology Residency Program.
 
 
Using leading edge technology, the Department of Radiation Oncology offers specialized services in external beam radiation therapy, radioactive seed implantation for prostate cancer, stereotactic radiosurgery and image guided intensity modulated radiation therapy. We also offer novel approaches to cancer therapy, such as radioimmunotherapy and helical tomotherapy. Through innovative laboratory and clinical research programs, we continue to investigate ways to further advance the efficacy and safety of radiation therapy.

Application Process

Application Process

How to Apply
 
 
Application Checklist
 
  • ERAS application
  • Official college, graduate school and medical school transcripts
  • An official record of board scores (NBME, FLEX, USMLE, LMCC, COMLEX, VQE or FMGEMS).
  • A dean's letter and two other letters of recommendation.
  • A curriculum vita.
  • A personal statement.
 
 
Graduates from a medical school outside of the United States or Canada must submit a valid ECFMG certificate.

Applications for each academic year, which begins July 1, should be completed by December 1 of the previous calendar year. If you are selected for an interview, you will be invited to visit City of Hope for an interview with selected faculty. Interviews are conducted from late November through early February each year.
 
Contact
 
For further information, contact the program by phone or email:
 
Thalia Yaden
Residency Program Coordinator
City of Hope Department of Radiation Oncology
1500 E. Duarte Road, Duarte, CA 91010
Telephone: 626-301-8247, ext. 64163
radiationresident@coh.org
 

Faculty

Faculty

In addition to caring for patients in their clinical practices, the City of Hope Department of Radiation Oncology faculty members are committed to teaching and facilitating the growth of medical knowledge.

Faculty members in the Department of Radiation Oncology include:
 
Radiation Oncologists:
 
  • Jeffrey Wong, M.D., FASTRO Chair
 
  • Eric Radany, M.D., Ph.D., Program Director
 
  • Richard Pezner, M.D.
 
  • Nayana Vora, M.D.
 
  • Yi-Jen Chen, M.D., Ph.D.
 
  • Khanh Nguyen, M.D.
 
  • Andrew Raubitschek, M.D. (Radioimmunotherapy)
 
 
 
Physicist:
 
  • Timothy Schultheiss, Ph.D. FACR, FAAPM, FASTRO, Director of Radiation Physics Cecil Staud, Ph.D.
 
  • An Liu, Ph.D.
 
  • Chun-Hui Han, Ph.D.
 
  • Sean Sun, M.S.
 
  • Lawrence Williams, Ph.D., FACR (Diagnostic Imaging)
 
  • James Bading, Ph.D. (Radioimmunotherapy)
 
 
 
Radiation Biology
 
  • Binghui Shen, Ph.D., Director, Radiation Biology
 
  • Jeremy Stark, Ph.D.
 
  • Fong-Fong Chu, Ph.D.
 

Facility and Department

Facility and Department

City of Hope is recognized worldwide for its compassionate patient care, innovative science and translational research, which rapidly turns laboratory breakthroughs into promising new therapies. We are one of only 41 National Cancer Institute-designated Comprehensive Cancer Centers nationwide and a founding member of the National Comprehensive Cancer Network. 
 
On our park-like campus just northeast of Los Angeles, City of Hope Helford Clinical Research Hospital brings groundbreaking research and compassionate care under one roof. It embodies our mission to deliver the newest, most promising therapies to patients without delay, while creating an environment that encourages open collaboration between physicians, caregivers and clinical researchers.
 
City of Hope Department of Radiation Oncology treats more than 900 patients each year. The department is equipped with state-of-the art technology, with facility renovation underway.  The department offers the full spectrum of radiation therapy modalities, including:
 
  • External beam radiation therapy with high-energy photons and electrons.
  • 3-D Conformal Radiation Therapy
  • IMRT -- Intensity Modulated Radiation Therapy
  • IGRT -- Image Guided Radiation Therapy
  • Stereotactic Radiosurgery
  • Total Body and Total Marrow Irradiation in conjunction with a Bone Marrow Transplant
  • Brachytherapy with LDR and HDR techniques
  • Treatment with Unsealed Sources, including targeted radiopharmaceuticals and radio-immunotherapy
 
 

Therapy Equipment 
 
  • Two Helical TomoTherapy – IGRT units
  • One Varian 21EX dual energy (6 MeV and 10 MeV), MLC linear accelerators with multiple electron capability and IMRT
  • One 6 MeV Varian linear accelerators.
  • Varian high dose-rate afterloader for interstitial and intracavitary implants.
  • Variety of low dose-rate sources available for implantation.
  • Ultrasound guided equipment for permanent prostate seed implants. Equipment to be added soon
  • One Varian Trilogy dual energy with CBCT/OBI and SRS/SRT capable.
  • One Varian iX dual energy accelerator with CBCT/OBI
 
Planning / Verification Equipment
 
  • Large bore CT-Simulation unit, dedicated for treatment planning
  • One Varian conventional simulator
  • Varian Eclipse Treatment Planning System
  • TomoTherapy Treatment Planning System
  • IMPAC Radiation Oncology Management System
 
Planning Equipment to be added soon
 
  • GE multi slice PET/CT simulator dedicated to planning and response assessment
  • GE 1.5T MRI dedicated to radiation oncology planning and response assessment
 
Conferences
Residents will be required to attend various radiation oncology conferences each week, as well as multidisciplinary conferences. An integrated, multidisciplinary approach to patient management is stressed. 
 
Multidisciplinary clinics or tumor boards occur in breast cancer; GU/prostate cancer, sarcomas, head and neck cancers; pediatric cancers; gynecological malignancies; gastrointestinal cancers; central nervous system cancers; and lymphomas. There is frequent interaction between all specialties which care for these patients including medical oncology, pediatric oncology, general surgery, head and neck surgery, the bone marrow transplantation service, pain service, neurosurgery, gynecological oncologists, thoracic surgery, and other ancillary services. 
 
Residents are a vital and important part of this multidisciplinary approach to the treatment of patients with cancer.
 
Fellowships and Residencies
City of Hope offers a number of exciting fellowships and residencies in laboratory cancer and diabetes research, administration, clinical applications and other areas.

City of Hope is one of only 41 Comprehensive Cancer Centers in the country, the highest designation awarded by the National Cancer Institute to institutions that lead the way in cancer research, treatment, prevention and professional education.
Beckman Research Institute of City of Hope is internationally  recognized for its innovative biomedical research.
Students and professionals at City of Hope can access a plethora of medical databases, scientific journals, course materials, special collections, and other useful resources at our 12,000 square foot Lee Graff Library.
City of Hope has a long-standing commitment to Continuing Medical Education (CME), sharing advances in cancer research and treatment with the health-care community through CME courses such as conferences, symposia and other on and off campus CME opportunities for medical professionals.
Learn more about City of Hope's institutional distinctions, breakthrough innovations and collaborations.


NEWS & UPDATES
  • Valentine’s Day is synonymous with dinner reservations, red roses, heart-shaped boxes of chocolates and — more often than not — unrealistically high expectations. Managing those expectations is great advice for all couples on Feb. 14 — and is especially important for couples confronting a cancer diagnosis. Focu...
  • With measles, what starts at a theme park in California definitely doesn’t stay at a theme park in California. Since the beginning of the current measles outbreak – traced to an initial exposure at Disneyland or Disney California Adventure during December – more than 100 people have been diagnosed with a diseas...
  • Even the most loving and secure relationship can be rattled by a life-threatening illness. When a woman is diagnosed with breast cancer, research shows one of the most important factors in helping her cope is having a supportive partner. But that partner can struggle with knowing what to say or how to best supp...
  • It’s been more than a century since Nobel Laureate Paul Ehrlich popularized the idea of a “magic bullet” targeting disease. Cancer researchers ever since have remained in hot pursuit of targeted therapies that home in on cancer cells while leaving normal cells unaffected. Linda Malkas, Ph.D., associate chair of...
  • Cancer patients face a daunting journey marked by challenges and uncertainties. For those undergoing bone marrow, or stem cell, transplantation, one complication poses a particular threat — chronic graft-versus-host disease (GVHD). Now, one researcher may have found a better way to control that threat. GVHD res...
  • Michele Dahlstein, a 50-year-old breast cancer survivor from Upland, California, celebrated her last day of chemotherapy on Dec. 30. She shares her story in her own words: I was diagnosed with breast cancer (invasive ductal carcinoma stage 2) on Aug. 11, 2014, after my yearly mammogram at City of Hope’s W...
  • The treatment of urologic cancers, including bladder cancer, is rapidly evolving. Here, urologic oncologic surgeon and kidney stone specialist Donald Hannoun, M.D., an assistant clinical professor in the Division of Urology and Urologic Oncology at City of Hope | Antelope Valley, explains the changes in hi...
  • A woman confronting metastatic breast cancer faces challenges that, at the outset, seem overwhelming. Research tells us these patients are especially vulnerable to anxiety, depression, hopelessness and other sources of distress. At the same time, they are asked to make complicated choices about their medical ca...
  • California health officials are opting to be safe rather than sorry when it comes to e-cigarettes. The increasingly popular devices are a public health threat, according to a California Department of Health report released Jan. 28. The department is seeking statewide regulation of e-cigarettes, saying they  emi...
  • “Not beyond us.” On World Cancer Day, researchers and caregivers around the globe are embracing this refrain. Specifically, the day calls for action to support healthier lifestyles, early cancer detection, quality of life and access to care. In a time of impressive scientific discovery and narrowing...
  • With more advanced cancer treatments and therapies saving lives every day, it’s safe to say cancer is “Not beyond us,” the official tagline for this year’s World Cancer Day. This year’s World Cancer Day observance takes place on Wednesday, Feb. 4, and focuses on cancer prevention, detection an...
  • Does our environment increase our risk of cancer? What about plastic bottles, radiation, chemicals, soy products …? Do they cause cancer? With so many cancer fears, rumors and downright urban legends circulating among our friends and colleagues, not to mention in the media and blogosphere, why not ask the...
  • With this week’s World Cancer Day challenging us to think about cancer on a global scale, we should also keep in mind that daily choices affect cancer risk on an individual scale. Simply put, lifestyle changes and everyday actions can reduce your cancer risk and perhaps prevent some cancers. According to ...
  • If you haven’t heard the term “precision medicine,” you will. If you don’t have an opinion about access to it, you will. On Friday, President Barack Obama unveiled details of the Precision Medicine Initiative, an effort intended to accelerate cancer research in a powerful way, giving doctors new knowledge and n...
  • The lack of a practical way to produce and store enough stem cells for larger-scale therapies and clinical trials is creating a bottleneck in stem cell research. A new grant to City of Hope from the California Institute for Regenerative Medicine (CIRM) will help solve that problem. The $899,728 grant, awarded T...